GENE ONLINE|News &
Opinion
Blog

2022-07-14| R&D

New Mitochondrial Response Pathway May Advance Treatments for Inflammatory Diseases

by Fujie Tham
Share To

In a study published on Immunity, University of California San Diego researchers described the biochemical pathway that results in the generation of oxidized mtDNA, how mitochondria expel it and cause the powerful and catastrophic inflammatory response observed in autoimmune conditions like lupus and rheumatoid arthritis.

Each mitochondrion contains copies of mitochondrial DNA (mtDNA). In response to cell damage or stress, mtDNA is expelled from the mitochondrion, oxidized, cleaved, and then triggers immune and inflammatory responses. mtDNA release into the cytosol or bloodstream can occur as a response to sepsis, traumatic injury, or cytotoxicity. While the concentration of circulating oxidized mtDNA in the bloodstream corresponds with the severity of autoimmune conditions, scientists are still unsure if mtDNA is simply a biomarker or if it plays a significant role in disease pathology.

Related article: TALED Tool Launches a New Era of Mitochondrial Genome Editing

 

Critical Role of FEN1 in Fueling the “Auto-Inflammatory Fire”

 

The researchers discovered that when macrophages come in contact with metabolic stress/danger signals, the mitochondria reacted to take up calcium ions from the cytosol, resulting in the generation and release of oxidized mtDNA (Ox-mtDNA) through the opening of mitochondrial permeability transition pores.

However, oxidized mitochondrial DNA is large, making it unlikely to escape via the pores on the mitochondrial membrane. The team identified that endonuclease FEN1 is responsible for cleaving large mtDNA into smaller segments, allowing escape and leading to further inflammatory activations. These smaller mtDNA fragments then go on to activate NLRP3 and cGAS, NLRP3 is part of a multi-protein complex called the inflammasome that activates inflammatory responses, while cGAS is an enzyme that generates a small molecule that acts as a chemical messenger to encourage the production of other cytokines. Overexcitation of both NLRP3 and cGAS is characteristic in patients with autoimmune diseases, where the immune system attacks normal body tissues.

These new findings shed light on how mitochondria affect the immune system with the pathway, FEN1’s role in triggering the immune cascade, and how possible therapeutic interventions may be developed for autoimmune diseases such as lupus and arthritis.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Netherlands-based Argenx Raises $1.1 Billion in Global Offering Following Success in Clinical Trials
2023-07-23
M&A
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
LATEST
An Interview with the Inventor of HPV Vaccine, Ian Frazer, Building a Firewall for Public Health
2024-02-29
Taiwan’s Drug Price Adjustments: Balancing Cost and Availability
2024-02-28
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Breakthrough Study Shows Anti-IgE Antibody Safeguards Children with Multiple Food Allergies
2024-02-27
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
EVENT
Scroll to Top